Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome.
about
Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Age does not adversely influen ...... and myelodysplastic syndrome.
@en
Age does not adversely influen ...... and myelodysplastic syndrome.
@nl
type
label
Age does not adversely influen ...... and myelodysplastic syndrome.
@en
Age does not adversely influen ...... and myelodysplastic syndrome.
@nl
prefLabel
Age does not adversely influen ...... and myelodysplastic syndrome.
@en
Age does not adversely influen ...... and myelodysplastic syndrome.
@nl
P2093
P2860
P356
P1476
Age does not adversely influen ...... L and myelodysplastic syndrome
@en
P2093
J P Uberti
M Ventimiglia
V Ratanatharathorn
P2860
P2888
P304
P356
10.1038/BMT.2017.182
P407
P50
P577
2017-09-04T00:00:00Z